We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+27.4%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$409M
AUM Growth
+$1.31M
Cap. Flow
-$55.4M
Cap. Flow %
-13.56%
Top 10 Hldgs %
9.96%
Holding
345
New
97
Increased
17
Reduced
117
Closed
103

Sector Composition

Rank Sector Weight
1 Healthcare 29.79%
2 Technology 25.64%
3 Industrials 15.05%
4 Consumer Discretionary 9.18%
5 Financials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWST icon
26
Casella Waste Systems
CWST
$5.76B
$2.98M 0.73%
75,226
-8,563
-10% -$321K
LOVE icon
27
LoveSac
LOVE
$242M
$2.93M 0.72%
94,171
+26,914
+40% +$925K
UPBD icon
28
Upbound Group
UPBD
$1.22B
$2.85M 0.7%
+106,882
New +$2.54M
PRFT
29
DELISTED
Perficient Inc
PRFT
$2.83M 0.69%
+82,425
New +$2.53M
BOOM icon
30
DMC Global
BOOM
$111M
$2.78M 0.68%
43,880
-17,514
-29% -$1.16M
NXRT
31
NexPoint Residential Trust
NXRT
$689M
$2.77M 0.68%
66,985
-10,867
-14% -$424K
ADVM
32
DELISTED
Adverum Biotechnologies
ADVM
$2.76M 0.67%
+23,204
New +$1.92M
RETA
33
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.73M 0.67%
28,933
-8,984
-24% -$776K
LAB icon
34
Standard BioTools
LAB
$342M
$2.72M 0.67%
221,082
-165,772
-43% -$2.11M
UPLD icon
35
Upland Software
UPLD
$13.3M
$2.7M 0.66%
5,932
-789
-12% -$361K
JYNT icon
36
The Joint Corp
JYNT
$119M
$2.7M 0.66%
148,304
-28,682
-16% -$488K
LSCC icon
37
Lattice Semiconductor
LSCC
$16B
$2.61M 0.64%
178,713
-98,691
-36% -$1.32M
BHVN
38
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.6M 0.64%
59,383
-2,453
-4% -$138K
BAND
39
Bandwidth Inc
BAND
$1.19B
$2.59M 0.63%
34,553
-5,790
-14% -$422K
CYRX icon
40
CryoPort
CYRX
$753M
$2.58M 0.63%
+141,088
New +$2.24M
EHTH icon
41
eHealth
EHTH
$41.9M
$2.56M 0.63%
29,771
-14,180
-32% -$954K
INSP icon
42
Inspire Medical Systems
INSP
$1.47B
$2.54M 0.62%
41,872
-8,122
-16% -$438K
RARX
43
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$2.51M 0.61%
83,611
-4,462
-5% -$102K
KIDS icon
44
OrthoPediatrics
KIDS
$513M
$2.51M 0.61%
64,414
-115
-0.2% -$4.64K
CVRS
45
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$2.4M 0.59%
806,746
-1,410
-0.2% -$3.53K
PAR icon
46
PAR Technology
PAR
$716M
$2.4M 0.59%
85,028
-170
-0.2% -$4.38K
CFMS
47
DELISTED
Conformis, Inc. Common Stock
CFMS
$2.39M 0.58%
+21,902
New +$1.8M
DECK icon
48
Deckers Outdoor
DECK
$14.1B
$2.29M 0.56%
78,216
-7,158
-8% -$186K
CLAR icon
49
Clarus
CLAR
$125M
$2.27M 0.56%
157,926
+82,046
+108% +$1.09M
EIDX
50
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$2.22M 0.54%
+71,461
New +$1.94M

Similar funds

EAM Investors's Q2 2019 Portfolio in Review

As of Q2 2019, EAM Investors held 345 positions worth $409M, up 0.32% from $408M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

EAM Investors withdrew a net $55.4M in Q2 2019, closing 103 positions and reducing 117 holdings. Its most notable exit was Pareteum Corporation, an estimated $3.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in Upbound Group worth $2.85M.

  • EAM Investors's largest Q2 2019 buy was Upbound Group: 106,882 shares worth $2.85M.
  • EAM Investors added most to Krystal Biotech in Q2 2019, an estimated $1.92M increase.
  • EAM Investors's biggest Q2 2019 reduction was Codexis, cutting an estimated $2.65M.
  • EAM Investors fully exited Pareteum Corporation in Q2 2019, selling an estimated $3.8M.
  • EAM Investors's ten largest holdings make up 10% of its $409M portfolio in Q2 2019.
  • EAM Investors opened 97 new positions and closed 103 in Q2 2019.
  • EAM Investors's portfolio value rose 0.32% quarter-over-quarter to $409M.

Based on EAM Investors's 13F filing for Q2 2019, filed 14 Aug 2019.